Chr. Hansen Holding A/S (CHYHY) Stock Price, News & Analysis

Company Overview

Chr. Hansen Holding A/S was a Danish bioscience company that developed and produced natural ingredients for the food, health and agricultural industries. Its products included microbial cultures, probiotics, enzymes, natural colors and other fermentation-based solutions used by food and beverage manufacturers, pharmaceutical companies and agricultural businesses.

The company’s cultures and enzymes supported applications such as dairy, plant-based foods, cheese, meat and fermented beverages. Its health-related products included probiotic strains and other microbial ingredients, while its agricultural offerings were designed to support animal health, feed efficiency and crop-related applications. Chr. Hansen served customers across Europe, North America, Asia and other international markets.

Chr. Hansen traced its origins to 1874, when Danish pharmacist Christian D.A. Hansen began producing microbial cultures for the dairy industry. The company was led by Chief Executive Officer Mauricio Graber before combining with Novozymes in 2023. The merged business operates as Novonesis, meaning Chr. Hansen Holding A/S is primarily of historical interest as the former listed company and brand.

Key Stats

• Today's Range: $19.42 to $19.86
• 50-Day Range: $19.59 to $19.59
• 52-Week Range: $14.73 to $25.32
• Volume: 7,300 shs
• Average Volume: 13,855 shs
• Market Capitalization: N/A
• P/E Ratio: 38.78
• Dividend Yield: 0.83%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: OTCMKTS:CHYHY
• CIK: N/A
• Web: www.chr-hansen.com
• Phone: (454) 574-7474
• Fax: N/A
• Employees: 3,834
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 38.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A